Tarsons Products Ltd

₹ 707 3.07%
02 Feb 2:20 p.m.
About

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]

Key Points

India’s Leading Labware Company[1] With over 36 years of operations, Tarson is one of the top three labware manufacturing companies in India and has a market share of 9-12% of labware market in India.

  • Market Cap 3,763 Cr.
  • Current Price 707
  • High / Low 914 / 539
  • Stock P/E 40.5
  • Book Value 100.0
  • Dividend Yield 0.00 %
  • ROCE 35.3 %
  • ROE 27.4 %
  • Face Value 2.00

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 27.8%

Cons

  • Stock is trading at 7.20 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
42 60 68 69 76 71 85 69 71
30 30 33 32 38 38 41 37 39
Operating Profit 12 31 35 37 38 33 44 31 33
OPM % 27% 51% 52% 53% 51% 47% 52% 45% 46%
2 2 1 2 1 2 3 3 4
Interest 1 1 1 1 2 1 0 0 1
Depreciation 3 3 3 5 5 5 7 6 7
Profit before tax 9 28 32 33 34 29 39 27 29
Tax % 26% 26% 25% 26% 26% 26% 25% 26% 25%
Net Profit 7 21 24 25 25 21 29 20 21
EPS in Rs 362.64 1,095.21 1,225.81 4.88 4.89 4.04 5.54 3.82 4.03
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
179 176 229 301 295
107 107 125 148 154
Operating Profit 72 69 103 153 141
OPM % 40% 39% 45% 51% 48%
6 4 5 8 11
Interest 7 6 3 4 3
Depreciation 15 14 14 22 26
Profit before tax 56 53 92 135 124
Tax % 30% 24% 25% 25%
Net Profit 39 41 69 101 93
EPS in Rs 2,027.06 2,108.74 3,583.25 18.92 17.43
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 19%
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 37%
TTM: -2%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 0%
Return on Equity
10 Years: %
5 Years: %
3 Years: 28%
Last Year: 27%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
0 0 0 11 11
Reserves 135 197 244 479 521
65 36 34 22 62
12 15 18 33 35
Total Liabilities 212 249 296 544 629
89 92 120 189 199
CWIP 7 19 22 32 74
Investments 0 0 0 0 0
116 137 153 323 356
Total Assets 212 249 296 544 629

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022
51 64 68 83
-34 -26 -64 -138
-18 -14 -27 130
Net Cash Flow -0 25 -23 75

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 91 79 75 79
Inventory Days 333 365 277 478
Days Payable 14 44 35 75
Cash Conversion Cycle 409 400 317 482
Working Capital Days 160 149 108 150
ROCE % 27% 37% 35%

Shareholding Pattern

Numbers in percentages

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
47.30 47.31 47.31 47.31 47.31
9.33 9.12 9.33 9.90 9.60
6.33 7.76 8.06 8.13 8.52
37.04 35.82 35.31 34.67 34.59

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents